Abstract
Sepsis is the sixth most common reason for hospitalization in the United States [1], with severe sepsis being the leading cause of in-hospital death [2]. Over 750,000 people develop sepsis annually, and almost one in four of these people die [1, 2]. Sepsis has an in-hospital mortality rate of approximately 16 %; this is eight times higher than other stays [1].
Access provided by CONRICYT-eBooks. Download reference work entry PDF
Similar content being viewed by others
Keywords
- Septic Shock
- Blood Culture
- Severe Sepsis
- Systemic Inflammatory Response Syndrome
- Multiple Organ Dysfunction Syndrome
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
General Principles
Public Health and Economic Burden
Sepsis is the sixth most common reason for hospitalization in the United States [1], with severe sepsis being the leading cause of in-hospital death [2]. Over 750,000 people develop sepsis annually, and almost one in four of these people die [1, 2]. Sepsis has an in-hospital mortality rate of approximately 16 %; this is eight times higher than other stays [1].
From 1997 to 2008, the cost of treating patients hospitalized for sepsis in the United States increased by almost 12 % annually. This increase may be attributed to an aging population with more chronic illnesses, greater use of invasive procedures, immunosuppressive drugs, chemotherapy, transplantation, and increasing microbial resistance to antibiotics. Hospitalization rates for sepsis increase with advanced age; patients over 65 years account for more than two thirds of sepsis hospitalizations in the United States [1, 3]. Globally, it is estimated that 18 million people are diagnosed with sepsis annually [4]. The case-fatality rate depends on the setting and severity of disease. Mortality can be as high as 30 % for sepsis, 50 % for severe sepsis, and 80 % for septic shock [5]. Escherichia coli is the most commonly identified organism in patients with a primary diagnosis of sepsis, while methicillin-resistant Staphylococcus aureus (MRSA) is most common for patients with a secondary diagnosis of sepsis [3].
Definitions and Classification
Bacteremia is the presence of viable bacteria in circulating blood. Bacteremia is usually associated with a symptomatic infection and is demonstrable by bacterial growth from an aseptically collected blood culture specimen [6]. Bacteremia often occurs transiently without any clinical consequences.
Systemic inflammatory response syndrome (SIRS) is an uncontrolled inflammatory response to an insult without probable or documented infection [7]. The clinical manifestations of SIRS are often identical to those occurring in sepsis and may occur in a number of conditions (Table 1). Therefore, it is important to exclude sepsis when SIRS is diagnosed. Excluding sepsis is often a challenge, as microbiological investigations are often negative for various reasons including antibiotic administration prior to sample collection or technical issues related to blood culture. Only 30–60 % of patients diagnosed with sepsis have positive blood cultures [9]. Negative or inconclusive blood cultures do not exclude the possibility of sepsis in patients when there is a high index of suspicion. In the clinical setting, the diagnosis of sepsis is often made retrospectively.
Sepsis is defined as a known or suspected infection plus systemic manifestations of infection [10].
Severe sepsis is sepsis with infection-induced organ dysfunction or infection-induced acute tissue hypoperfusion. Organ dysfunctions associated with sepsis include acute lung injury, acute kidney injury, coagulopathy, liver dysfunction, and cardiovascular abnormalities. Sepsis-induced tissue hypoperfusion abnormalities include hypotension, elevated lactate, oliguria, and altered mental status [10].
Septic shock is defined as sepsis-induced hypotension which is not responsive to adequate fluid resuscitation [9].
Multiple organ dysfunction syndrome (MODS) is a progressive organ dysfunction in an acutely ill patient such that homeostasis cannot be maintained without intervention. It is at the severe end of the severity spectrum of both SIRS and sepsis.
The sepsis spectrum begins with infection, which progresses to bacteremia, sepsis, severe sepsis, septic shock, and death.
Approach to the Patient
Clinical presentation: Early identification and appropriate evidence-based medical care are key to increasing the chance of survival and improving overall outcomes in sepsis [1, 10, 11].
The most common sites of infection are the respiratory, genitourinary, and gastrointestinal systems, as well as the skin and soft tissue [12]. These sites account for over 80 % of all cases of sepsis [13]. Among nursing home residents 65 and older, the urinary tract was found to be the most common source of sepsis [14].
Overall, fever is often the first manifestation of sepsis [12]. However, neonates, immunocompromised or chronically ill patients, and the elderly may have sepsis without meeting the sepsis criteria. Therefore, clinical suspicion is key to appropriate and timely diagnosis. In the elderly, for example, failure to eat, withdrawal, agitation, disorientation, and confusion may be early signs of sepsis [12, 15]. In neonates, exaggerated physiologic jaundice, tachypnea, poor feeding, and reduced tone may be the only manifestations of sepsis.
History taking focused on the chief complaint with a pertinent review of systems is often adequate for initial triage. However, some patient with sepsis may present with nonspecific constitutional symptoms necessitating a more detailed history.
Physical Examination A complete physical examination is indicated. This is important because sepsis from an infection in less obvious areas such as the pelvis or perineum may occur. However, a thorough physical examination should not delay early initiation of life-saving care. General and hemodynamic variables that may indicate sepsis (Table 2) should be carefully noted to aid in the early identification of patients in the sepsis spectrum.
Diagnosis
Laboratory Workup and Imaging
Laboratory findings consistent with sepsis are as outlined in Table 2. Routine laboratory workup for sepsis includes two sets of blood cultures (drawn before starting antibiotics if possible). Urinalysis, urine culture, and cultures from other suspected sites (wound, respiratory secretions, CSF, or other body fluids) are also appropriate. Other laboratory tests and imaging studies should be individualized based on history and physical examination findings.
Lactate levels have been strongly correlated with mortality [17, 18].
Differential Diagnosis
Various conditions can mimic sepsis. Although the differential is very broad, Table 1 includes common causes of SIRS other than sepsis.
Treatment
Aggressive and timely management of patients with sepsis is paramount. Expeditious transfer to an inpatient setting should occur. Intravenous fluid resuscitation can be started in the ambulatory setting. Blood culture collection should not cause delay in necessary care at any point. Empiric antibiotics should be started after blood culture sample collection and in any case within 1 h of arrival at the hospital or emergency room. The antibiotic choice can be based on the patient’s history (e.g., recent antibiotics used), clinical context (community vs. health setting-acquired infection), most likely pathogens, local susceptibility patterns, and cost-effectiveness. Fluid resuscitation should be initiated and continued upon arrival to the emergency room or hospital. If septic shock is present, vasopressor therapy should be considered.
If a localized source of infection is detected, intervention (such as abscess drainage) should be undertaken as soon as possible within the first 12 h after the diagnosis is made [16].
The Surviving Sepsis Campaign (SSC) care bundle (Table 3) is a selected set of elements of care distilled from evidence-based practice guidelines. Using the bundle simplifies complex processes of care of patients with severe sepsis and has demonstrated marked improvements in survival rates after sepsis [19, 20].
Prevention
Patients at increased risk of sepsis should be appropriately vaccinated against pneumococci, Haemophilus influenzae type b, meningococci, and the influenza virus. The Centers for Disease Control (CDC) strategies for preventing infections include promotion of vaccination for diseases like pneumococcus and meningitis, smoking cessation programs to prevent community-acquired pneumonia, and strategies to prevent healthcare-associated infections [21]. Early identification and appropriate treatment of infection in all patients especially those at increased risk of sepsis reduces chances of progression to bacteremia and sepsis. Good nutrition and lifestyle changes (including regular exercise) boost the body’s natural defense system and ability to fight infection. Hand hygiene and good general hygiene practices reduce the rate of infection transmission. Antibiotic stewardship reduces the prevalence of bacterial resistance in the community.
Family and Community Issues
Sepsis survivorship is a substantial and under-recognized public health problem with major implications for patients, families, and the healthcare system. Sepsis survivors often develop physical , cognitive , and affective deficits in the months and years after discharge. These new deficits are relatively more severe among patients who were in good health prior to hospitalization for sepsis [22]. Declines in the level of functioning impact many areas of a patient’s life ranging from the ability to perform activities of daily living (ADL) to executive functioning. This may affect the structure and functioning of the family unit. Additional issues include caregiver fatigue, marital stress, and other psychosocial, medical, economic, and legal issues. It is important for family physicians to maintain vigilance for possible sequelae of sepsis among patients and their families beginning at the discharge planning phase of care. An understanding of immediate and long-term outcomes helps with managing expectations and setting goals of care especially when assessing options for short- or long-term care.
References
Hall MJ, Williams SN, DeFrances CJ, Golosinskiy A. Inpatient care for septicemia or sepsis: a challenge for patients and hospitals. NCHS data brief, no 62, vol 62. Hyattsville: National Center for Health Statistics; 2011. p. 1–8.
Saving Lives Through Better Sepsis Care. Kaiser Permanente Institute for Health Policy. Kaiser Permanente Policy Story, V1, no 4. Available from: http://www.kpihp.org/wp-content/uploads/2012/10/KPStories-v1-no4-Sepsis-FINAL-B.pdf
Elixhauser A (Agency for Healthcare Research and Quality), Friedman B (Agency for Healthcare Research and Quality), Stranges E (Thomson Reuters). Septicemia in U.S. Hospitals, 2009. HCUP Statistical Brief #122. October 2011. Rockville: Agency for Healthcare Research and Quality. Available from: http://www.hcup-us.ahrq.gov/reports/statbriefs/sb122.pdf
International Organizations Declare Sepsis a Medical Emergency. Issued by an expert panel representing 20 adult and pediatric intensive care societies, 4 Oct 2010. 2010; Press release. Available from: http://www.prnewswire.com/news-releases/international-organizations-declaresepsis-a-global-medical-emergency-104142073.html
Jawad I, Luksic I, Rafnsson SB. Assessing available information on the burden of sepsis: global estimates of incidence, prevalence and mortality. J Glob Health. 2012;2:010404.
Bennett NJ, Damachowske J, Holland BJ. Bacteremia. Medscape drugs & diseases. Updated 2 May 2014. Available at: http://emedicine.medscape.com/article/961169-overview
Carlson GL, Dark PM. General principles of sepsis. In: Bland K, Buchler M, Csendes A, Garden O, Sarr M, Wong J, editors. General surgery (2nd ed): principles and international practice. Berlin/Heidelberg: Springer; 2009. p. 241–50.
Kaplan LJ. Systemic inflammatory response syndrome. Medscape drugs & diseases. Published 18 Aug 2014. Available at: http://emedicine.medscape.com/article/168943-overview
Vincent JL, Sakr Y, Sprung CL, et al. Sepsis in European intensive care units: results of the SOAP study. Crit Care Med. 2006;34(2):344–53.
Dellinger RP. The surviving sepsis campaign 2014: an update on the management and performance improvement for adults in severe sepsis. Consultant. 2014;54(10):767–71.
Dellinger RP, Levy MM, Rhodes A, Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39(2):165–228. doi:10.1007/s00134-012-2769-8. Epub 2013 Jan 30.
Gauer RL. Early recognition and management of sepsis in adults: the first six hours. Am Fam Physician. 2013;88(1):44–53.
Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet. 2005;365(9453):63–78.
Mylotte JM, Tayara A, Goodnough S. Epidemiology of bloodstream infection in nursing home residents: evaluation in a large cohort from multiple homes. Clin Infect Dis. 2002;35(12):1484–90.
Holloway WJ. Management of sepsis in the elderly. Am J Med. 1986;80(6B):143–8.
Dellinger RP, Levy MM, Rhodes A, et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock, 2012. Intensive Care Med. 2013;39:165–228. doi:10.1007/s00134-012-2769-8.
Jansen TC, van Bommel J, Schoonderbeek FJ, LACTATE Study Group, et al. Early lactate-guided therapy in intensive care unit patients: a multicenter, open-label, randomized controlled trial. Am J Respir Crit Care Med. 2010;182(6):752–61.
Jones AE, Shapiro NI, Trzeciak S, Emergency Medicine Shock Research Network (EMShockNet) Investigators, et al. Lactate clearance vs central venous oxygen saturation as goals of early sepsis therapy: a randomized clinical trial. JAMA. 2010;303(8):739–46.
Levy MM, Ferrer R, Martin-Loeches I, et al. Empiric antibiotic treatment reduces mortality in severe sepsis and septic shock from the first hour: results from a guideline-based performance improvement program. Crit Care Med. 2014;42(8):1749–55.
Levy MM. Surviving sepsis campaign: the takeaways. CDC Expert Commentary, 10 Sep 2014. http://www.medscape.com/viewarticle/831158
Centers for disease control: sepsis, questions and answers. Available at: http://www.cdc.gov/sepsis/basic/qa.html. Accessed 16 Jan 2015
Iwashyna TJ, Ely EW, Smith DM, Langa KM. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA. 2010;304(16):1787–94.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Omole, F.S., Fasuyi, O.B. (2017). Bacteremia and Sepsis. In: Paulman, P., Taylor, R., Paulman, A., Nasir, L. (eds) Family Medicine. Springer, Cham. https://doi.org/10.1007/978-3-319-04414-9_45
Download citation
DOI: https://doi.org/10.1007/978-3-319-04414-9_45
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-04413-2
Online ISBN: 978-3-319-04414-9
eBook Packages: MedicineReference Module Medicine